KEGG pathways showed that some proteins were enriched in the glycosaminoglycan degradation, glyoxylate and dicarboxylate metabolism, diabetic cardiomyopathy, insulin secretion, and glycolysis/gluconeogenesis pathways, which are all associated with diabetes-related glucose metabolic disorders. This evidence concerns the gene INS and glucose metabolism disease.